2B will participate in the Project BlackBio

I think it's time to become more active in investment, after a few months in which he was not in my point of view a lot of sense to move, and especially economic risk-taking, I think we should start doing things, rather than by the overall situation, because we are living in fear, we have become accustomed to it.

It is no secret, although it is true that I have been very zealous in what I posted about this, I work for almost 1 ½ years with many others in the draft Genolab , and we can begin to provide information in brief but today does not play, today I wanted to take this opportunity to announce, as was made public yesterday, my participation in another innovator in the field of biotechnology.

I invested in a project that I particularly like, 2B BlackBio , a Spanish biotech company that was created with aim of leading to a scenario of personalized medicine based on genomics and proteomics, and will have as the main market in Europe, Asia and America, it is a company born from Spain with national and international capital and global.

For that reason and that a global approach has been presented Blackbio 2b 1 month ago Forum Deutsches Eigenkapitalforum in Germany, which is very unusual for a Spanish company. Just as participate in a few days Biomedica 2010 . Aachen, Germany.

This first round has closed an extension of 400,000 Euros of private capital, private investors have signed a number of national and international companies. In addition to my shareholding in the company, will be happy to be one of the directors of the same .

I think we're at a key stage Biotech companies, just visit USA to see that the line of Internet / technology and Cleantec Biotechnology and is increasingly fine, I would say almost nonexistent. It is an area where you have to be, and also for me to participate has a huge added, the first synergies and partnerships developed with Genolab, and in second case the presence as founder and CEO of Pedro Franco de Sarabia , founder one of the oldest companies in the sector in Spain, BioTools and reference person in the field of biotechnology.

2B BlackBio, will house developments and third, with focus on research in oncology, Wellness, Cardiovascular, Allergy, Microbiology and Pharmacogenomics, using various tools such as protein microarrays, real-time PCR

Currently BlackBio already has signed its first international patent, developed a revolutionary Biokit BlackLight Sepsis Kit (patent PCT ES2009 000 507), which identifies four hours in any bacterial infection, even without any symptoms where the infection could come

Also in short time more will be presented four patents on which the equipment works BlackBio months ago.

S i want you can follow me on Twitter

Tags: 2b blackbio , biotechnology , biotech , blackbio , Genolab , investment , patents , Pedro Sarabia franc